MORVEN EDWARDS to Immunoglobulin G
This is a "connection" page, showing publications MORVEN EDWARDS has written about Immunoglobulin G.
Connection Strength
0.500
-
Immune Responses to Invasive Group B Streptococcal Disease in Adults. Emerg Infect Dis. 2016 11; 22(11):1877-1883.
Score: 0.104
-
Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine. 2012 Jun 13; 30(28):4123-6.
Score: 0.076
-
Group B Streptococcus bacteremia elicits beta C protein-specific IgMand IgG in humans. J Infect Dis. 2007 Feb 01; 195(3):353-6.
Score: 0.052
-
Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons. Clin Infect Dis. 2005 Feb 01; 40(3):352-7.
Score: 0.046
-
Antibodies to type III group B streptococcal polysaccharide in breast milk. Pediatr Infect Dis J. 2004 Oct; 23(10):961-3.
Score: 0.045
-
Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus. J Am Geriatr Soc. 2004 Jan; 52(1):46-50.
Score: 0.043
-
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis. 2003 Jul 01; 188(1):66-73.
Score: 0.041
-
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun. 2002 Apr; 70(4):1724-38.
Score: 0.038
-
A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III. Clin Infect Dis. 2019 05 30; 68(12):2079-2086.
Score: 0.031
-
Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease. Vaccine. 2008 Jan 24; 26(4):502-8.
Score: 0.014
-
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis. 2004 Mar 15; 189(6):1103-12.
Score: 0.011